Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Richard Schulick to Protein-Tyrosine Kinases

This is a "connection" page, showing publications Richard Schulick has written about Protein-Tyrosine Kinases.

 
Connection Strength
 
 
 
0.134
 
  1. Harsha HC, Jimeno A, Molina H, Mihalas AB, Goggins MG, Hruban RH, Schulick RD, Kamath U, Maitra A, Hidalgo M, Pandey A. Activated epidermal growth factor receptor as a novel target in pancreatic cancer therapy. J Proteome Res. 2008 Nov; 7(11):4651-8.
    View in: PubMed
    Score: 0.064
  2. Schulick RD. Effective neoadjuvant therapy prior to metastasectomy: a new paradigm. Ann Surg. 2007 Mar; 245(3):353-4.
    View in: PubMed
    Score: 0.058
  3. Ravi R, Jain AJ, Schulick RD, Pham V, Prouser TS, Allen H, Mayer EG, Yu H, Pardoll DM, Ashkenazi A, Bedi A. Elimination of hepatic metastases of colon cancer cells via p53-independent cross-talk between irinotecan and Apo2 ligand/TRAIL. Cancer Res. 2004 Dec 15; 64(24):9105-14.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)